Tumor Suppressor Mechanisms in Cell Adhesion Dynamics

Tumour suppressor proteins orchestrate the stability and turnover of cell–cell and cell–matrix adhesions, acting as guardians of tissue architecture and regulators of signalling cascades that restrain malignant transformation. Central to these mechanisms are focal adhesions—multi-protein assemblies that connect integrin receptors to the actin cytoskeleton—and adherens junctions, anchored by cadherin–catenin complexes. Tumour suppressors modulate adhesive strength by influencing cytoskeletal remodelling, focal‐adhesion kinase activity and the balance of pro- and anti-adhesive signals. Loss or inactivation of these suppressors through genetic deletion, promoter hypermethylation or post-translational modifications leads to weakened cell adhesion, enhanced motility and increased invasive potential. Key effectors include LIM-domain proteins that serve as modular scaffolds at adhesion sites, MAP kinase pathways that integrate stress responses with adhesion dynamics and chromatin modifiers that regulate expression of adhesion-related genes. Collectively, these networks maintain tissue integrity, restrain metastatic dissemination and offer therapeutic entry points for restoring adhesion-dependent checkpoints in cancer.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Tumor Suppressor Mechanisms in Cell Adhesion Dynamics publication trend

The graph below shows the total number of articles in tumor suppressor mechanisms in cell adhesion dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Focal adhesion: A multi-protein complex that links integrin receptors to the actin cytoskeleton, mediating cell adhesion and signalling.

LIM domain: A double zinc-finger motif found in scaffold proteins that organises protein–protein interactions at adhesion sites.

Promoter hypermethylation: Addition of methyl groups to DNA cytosine residues in gene promoters, leading to transcriptional silencing.

p38 MAP kinase: A stress-activated protein kinase that modulates apoptosis, differentiation and cytoskeletal rearrangements.

Integrin: A transmembrane receptor family that mediates cell–extracellular matrix adhesion and initiates intracellular signalling.

References

1. TES functions as a Mena‐dependent tumor suppressor in gastric cancer carcinogenesis and metastasis. Cancer Communications (2019).
2. TES inhibits colorectal cancer progression through activation of p38. Oncotarget (2016).
3. The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactions. PLOS ONE (2017).